Adoptively transferred T-cells can prolong survival and sometimes cure patients with advanced solid tumors. While promising, it can take months to generate the necessary T-cells to help these patients. Such slow speed makes this therapy impractical for most patients who need immediate treatment. In the September issue of Cancer Research, Hannah Knochelmann, a student in… Read More »
A team of researchers from the Florida State University College of Medicine has found that an amino acid produced by the brain could play a crucial role in preventing a type of epileptic seizure. Temporal lobe epileptic seizures are debilitating and can cause lasting damage in patients, including neuronal death and loss of neuron function.… Read More »
As part of the global effort to manage and contain the coronavirus response, two global health standards organizations have introduced new content. Regenstrief Institute and SNOMED International, are supporting care teams globally to code and track SARS-CoV-2 testing and COVID-19 cases, and by extension support clinicians and researchers in their efforts to address its containment.… Read More »
What’s the outlook for really fending off the novel coronavirus? Small molecule drugs and other therapeutics will obviously beat vaccines to market, and Gilead’s remdesivir, if effective, could scale up fast, experts said. Vaccines are likely farther off than quoted timelines suggest. It’s “overly optimistic” to expect them in 12 to 18 months, two opinion leaders… Read More »
Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease. Researchers from Dana-Farber Cancer Institute report a response rate of 24 percent across all risk categories of patients given an oral first-in-class agent that targets hypoxia inducible factor (HIF) 2-a, which promotes… Read More »